Jeremy L. Stigall - 11 Mar 2026 Form 4 Insider Report for ClearPoint Neuro, Inc. (CLPT)

Role
Chief Business Officer
Signature
/s/ Danilo D'Alessandro, by Power of Attorney for Jeremy L. Stigall
Issuer symbol
CLPT
Transactions as of
11 Mar 2026
Net transactions value
$0
Form type
4
Filing time
13 Mar 2026, 15:08:11 UTC
Previous filing
10 Mar 2026
Next filing
16 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
STIGALL L. JEREMY Chief Business Officer C/O CLEARPOINT NEURO, INC., 120 S. SIERRA AVE., SUITE 100, SOLANA BEACH /s/ Danilo D'Alessandro, by Power of Attorney for Jeremy L. Stigall 13 Mar 2026 0001929859

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLPT Common Stock Options Exercise +8,291 +9.5% 95,862 11 Mar 2026 Direct F1
transaction CLPT Common Stock Tax liability -3,224 -3.4% $11.62* 92,638 11 Mar 2026 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLPT Restricted Stock Units Options Exercise -8,291 -100% 0 11 Mar 2026 Common Stock 8,291 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.
F2 Represents the amount of shares delivered to CLPT to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock.